TriSalus Life Sciences
Westminster
About TriSalus Life Sciences
TriSalus Life Sciences, based in Westminster, Colorado, was founded in 2009 to develop a novel infusion system for the interventional radiology market. The company's Infusion System is designed to precisely deliver embolic agents through the sophisticated expandable tip portion of its catheter. Because of this differentiated expandable tip, which collapses in forwarding flow to maintain blood flow and dynamically expands to the vessel wall in reverse flow to minimize reflux, Surefire's Infusion System is designed to substantially reduce damage to healthy tissue.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $193.6M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2026)
- Ticker: nasdaq:TLSI
- Website: trisaluslifesci.com
- Phone: +1 3034261223
Industries & Categories
Biotechnology, Developer Platform, Hardware, Medical
Social Profiles
Canonical: https://fsome.com/organization/trisalus-life-sciences-92526 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.